STEVEN C GILMAN Insider Trading $KERX KERYX BIOPHARMACEUTICALS INC
Get free email notifications about insider trading for STEVEN C GILMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN C GILMAN. STEVEN C GILMAN is EVP & Chief Scientific Officer in CUBIST PHARMACEUTICALS INC ($CBST) and Senior Vice President in CUBIST PHARMACEUTICALS INC ($CBST) and SVP, Chief Scientific Officer in CUBIST PHARMACEUTICALS INC ($CBST) and in Vericel Corp ($ASTM) and Director in Vericel Corp ($ASTM) and Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Director in SCYNEXIS INC ($SCYX) and Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and CEO in CONTRAFECT Corp ($CFRX) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA).
STEVEN C GILMAN in KERYX BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2018
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STEVEN C GILMAN in KERYX BIOPHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, CFRX, CBST, KERX, MNTA, SCYX, ASTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Option Exercise | D | 0.00 | 140,000 | 0 | 0 | |
| Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Sell | D | 0.00 | 27,333 | 0 | 0 | 27.3 K to 0 (-100.00 %) |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Option Exercise | A | 3.76 | 30,000 | 112,800 | 30,000 | |
| Jul 12 2018 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Grant | A | 0.00 | 10,000 | 0 | 27,333 | 17.3 K to 27.3 K (+57.69 %) |
| Jun 12 2018 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Sell | S | 5.12 | 1,334 | 6,830 | 17,333 | 18.7 K to 17.3 K (-7.15 %) |
| May 31 2018 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Sell | S | 5.22 | 1,333 | 6,958 | 18,667 | 20 K to 18.7 K (-6.66 %) |
| Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Option Exercise | A | 6.56 | 30,000 | 196,800 | 30,000 | |
| Jun 20 2017 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Grant | A | 0.00 | 10,000 | 0 | 20,000 | 10 K to 20 K (+100.00 %) |
| May 27 2016 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Option Exercise | A | 5.71 | 30,000 | 171,300 | 30,000 | |
| May 27 2016 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Page: 1